Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.smslife.in | |
Market Cap | 208.70 Cr. | |
Enterprise Value(EV) | 311.55 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 16.17 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 42.70 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.22 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 566.22 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 1.22 | Calculated using Price: 690.30 |
Dividend Yield | 0.22 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.30 Cr. | 3,023,287 Shares |
FaceValue | 10 | |
About SMS Lifesciences India Ltd. | ||
SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, API and Intermediates. |
1 Day |
|
-0.63% |
1 Week |
|
-6.04% |
1 Month |
|
+10.80% |
3 Month |
|
+20.59% |
6 Month |
|
+40.91% |
1 Year |
|
+23.57% |
2 Year |
|
-0.89% |
5 Year |
|
+21.35% |
10 Year |
|
5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 16.78 | 9.17 | 11.07 | 17.98 | 7.09 | |
Return on Capital Employed (%) | 20.14 | 11.91 | 12.96 | 18.42 | 9.44 | |
Return on Assets (%) | 6.45 | 3.83 | 4.82 | 7.54 | 2.98 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 106 | 116 | 129 | 152 | 169 | 167 | |
Non Curr. Liab. | 39 | 50 | 59 | 56 | 73 | 64 | |
Curr. Liab. | 132 | 90 | 119 | 143 | 137 | 135 | |
Minority Int. | 13 | 20 | 16 | ||||
Equity & Liab. | 276 | 256 | 307 | 364 | 398 | 383 | |
Non Curr. Assets | 128 | 146 | 176 | 201 | 236 | 236 | |
Curr. Assets | 149 | 110 | 131 | 164 | 163 | 147 | |
Misc. Exp. not W/O | |||||||
Total Assets | 276 | 256 | 307 | 364 | 398 | 383 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 378 | 261 | 266 | 350 | 316 | 280 | |
Other Income | 3 | 2 | 2 | 2 | 3 | 4 | |
Total Income | 380 | 263 | 267 | 352 | 319 | 284 | |
Total Expenditure | -343 | -235 | -235 | -316 | -287 | -258 | |
PBIDT | 37 | 28 | 32 | 36 | 32 | 26 | |
Interest | -6 | -5 | -5 | -6 | -7 | -9 | |
Depreciation | -6 | -8 | -8 | -10 | -11 | -14 | |
Taxation | -8 | -4 | -6 | -7 | -5 | -3 | |
Exceptional Items | 13 | 2 | 2 | ||||
PAT | 18 | 10 | 14 | 25 | 11 | 2 | |
Minority Interest | 0 | 0 | 3 | ||||
Share Associate | |||||||
Other Related Items | |||||||
Consolidated Net Profit | 18 | 10 | 14 | 25 | 11 | 5 | |
Adjusted EPS | 59 | 34 | 45 | 84 | 38 | 16 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 30 | 15 | 35 | -11 | 15 | |
Cash Fr. Inv. | -44 | -27 | -26 | -7 | -31 | |
Cash Fr. Finan. | 15 | 12 | -3 | 11 | 17 | |
Net Change | 1 | 0 | 6 | -8 | 0 | |
Cash & Cash Eqvt | 2 | 2 | 9 | 1 | 1 |
Thu, 11 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018 SMS Lifesciences India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
Thu, 28 Mar 2024
Trading Window SMS Lifesciences India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
Thu, 28 Mar 2024
Trading Window-XBRL SMS Lifesciences India Limited has informed the Exchange about Closure of Trading Window |
Wed, 24 Apr 2024 |
Closing Below Previous Low |
Making Lower Lows for 3 days |
Close Within 52 Week High Zone |
Making Lower Lows for 2 Days |
High Increase in 1 Month |